Leonteq Securities AG’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Buy
5,558
+2,030
+58% +$437K 0.05% 220
2026
Q1
$767K Buy
3,528
+2,073
+142% +$460K 0.03% 336
2025
Q4
$332K Sell
1,455
-3,707
-72% -$844K 0.01% 558
2025
Q3
$1.2M Buy
5,162
+3,976
+335% +$810K 0.04% 258
2025
Q2
$220K Buy
+1,186
New +$220K 0.01% 551
2025
Q1
Sell
-3,372
Closed -$599K 1229
2024
Q4
$599K Sell
3,372
-8,938
-73% -$1.64M 0.04% 316
2024
Q3
$2.43M Buy
12,310
+3,873
+46% +$723K 0.18% 118
2024
Q2
$1.45M Sell
8,437
-3,775
-31% -$625K 0.1% 163
2024
Q1
$2.22M Buy
12,212
+6,162
+102% +$1.06M 0.17% 138
2023
Q4
$938K Sell
6,050
-1,135
-16% -$165K 0.05% 258
2023
Q3
$1.07M Sell
7,185
-11,629
-62% -$1.71M 0.06% 251
2023
Q2
$2.53M Buy
18,814
+3,153
+20% +$462K 0.13% 169
2023
Q1
$2.5M Buy
15,661
+4,418
+39% +$675K 0.11% 162
2022
Q4
$1.82M Sell
11,243
-10,526
-48% -$1.61M 0.07% 213
2022
Q3
$2.92M Buy
21,769
+7,166
+49% +$1.03M 0.11% 152
2022
Q2
$2.24M Buy
14,603
+9,965
+215% +$1.52M 0.08% 187
2022
Q1
$752K Buy
+4,638
New +$674K 0.03% 349
2021
Q2
Sell
-1,492
Closed -$168K 1056
2021
Q1
$161K Buy
1,492
+971
+186% +$104K 0.01% 586
2020
Q4
$55.8K Buy
+521
New +$50.1K ﹤0.01% 766

Other funds holding ABBV

Leonteq Securities AG's ABBV Position: Q2 2026 in Review

Leonteq Securities AG increased its AbbVie (ABBV) stake by 58% in Q2 2026, buying an estimated $437K and bringing the position to 5,558 shares worth $1.4M. The position accounts for 0.05% of the portfolio, ranked #220.

Leonteq Securities AG first reported a position in ABBV in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.92M in Q3 2022. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Leonteq Securities AG held 5,558 shares of AbbVie worth $1.4M as of Q2 2026.
  • Leonteq Securities AG bought 2,030 AbbVie shares in Q2 2026, an estimated $437K.
  • AbbVie made up 0.05% of Leonteq Securities AG's portfolio in Q2 2026, its #220 holding.
  • Leonteq Securities AG first reported a position in AbbVie in Q4 2020 and has held it in 19 quarters since.
  • Leonteq Securities AG's AbbVie position peaked at $2.92M in Q3 2022.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.